Good day,
Thank you for subscribing to the Earnings360 newsletter, your daily source for quarterly earnings news and updates.
Each morning edition contains a wrap-up of today's pre-market earnings announcements and yesterday's earnings announcements after the closing bell.
Before we send you your first edition, please take a moment to confirm your subscription below. We will not be able to send your newsletter until you confirm your subscription.
Confirm Your Subscription Here
The Earnings360 Team
Today's Bonus Story Why Procter & Gamble Remains a Buy-and-Hold FavoriteWritten by Thomas Hughes. Published 10/27/2025. 
Key Points - Procter & Gamble is well-positioned to deliver market-beating total returns over the next two to five years.
- A low valuation, high yield, and outlook for sustained revenue and earnings growth underpin the outlook.
- Analysts and institutional trends suggest PG stock bottomed in Q3 2025 and is poised to move higher from there.
Procter & Gamble (NYSE: PG) is a compelling choice for long-term total returns. Its stock price sits near the low end of its historical P/E range, its dividend yield is toward the high end of its typical range, and its FQ1 2026 results support a positive outlook for growth, cash flow, and capital returns. What are total returns? Total returns measure an investor's net gain, including dividends and share price appreciation. As of late October, the stock yields roughly 2.75% and could rise 25% or more over the coming years. Warren Buffett is the greatest value investor of all time. But even the Oracle of Omaha has limits.
Because of Berkshire Hathaway's size, Buffett simply can't invest in small-cap stocks without taking controlling stakes. That means some of the market's most promising companies are completely off his radar.
But they don't have to be off yours.
We've put together a brand-new report profiling 5 small-cap stocks that check all the boxes of Buffett's investing criteria solid financials, durable business models, strong management, and clear growth catalysts.
The only difference?
These stocks are flying under Wall Street's radar and still accessible to individual investors like you. >> Click here to get your free copy of this report Price appreciation should be supported by the company's high-quality business, steady growth, a healthy balance sheet, and robust capital returns, including share repurchases. Share repurchases are particularly important for the stock's outlook because they reduce the share count at a semi-aggressive pace each year and are unlikely to be suspended in the near term. The dividend is attractive, with a yield above 2.5%. Another tailwind is the company's track record and capacity for payout increases. Procter & Gamble is a Dividend King with 70 consecutive years of annual dividend raises and appears well-positioned to continue increasing the dividend for the foreseeable future (see analysis). Buybacks also help offset the cost of higher distributions. The payout ratio is reasonable at about 65%, in line with peers, and consensus forecasts reported by MarketBeat anticipate a mid-single-digit EPS CAGR—slightly above revenue growth and consistent with the company's dividend growth trajectory. 
Procter & Gamble Rises After Posting Solid Results Procter & Gamble's FQ1 results were solid, beating expectations on both the top and bottom lines with reported revenue growth of 3.0%. Much of the strength came from FX translation and price increases, but all segments contributed, and some delivered organic growth. Beauty and Grooming posted organic gains, helping to drive a 2% organic increase for the business. Margins were another bright spot. While the company faced margin pressures, it mitigated those headwinds better than anticipated. The quarter produced $5.4 billion in operating cash flow, $4.8 billion in net earnings, and a 3% increase in adjusted EPS. The $1.99 adjusted EPS was nearly 500 basis points above consensus expectations, suggesting the company's guidance may be conservative. Procter & Gamble reaffirmed its earnings guidance, with a midpoint slightly below the consensus estimate. Management expects some weakening in upcoming quarters to offset Q1 strength, but that view may understate consumer resiliency seen in this and other consumer-focused companies' recent reports. The likely scenario is that Procter & Gamble will outperform in coming quarters, prompting improved guidance later in the year. Institutional and Analyst Trends Align With a Bottom for PG Stock Price Analyst and institutional trends point to a potential bottom in the PG share price. Analysts rate the stock a Moderate Buy and expect double-digit upside, while institutions have been net buyers. This year, institutions bought more than $2.50 for every $1.00 sold, and they now own roughly 65% of outstanding shares—providing a solid support base. A move to the consensus target would position the stock for new highs, likely in 2026. The technical picture is constructive. PG's price jumped about 2.5% in premarket trading on Oct. 24, confirming a bottom near $147. If the market follows through, PG should regain support around the moving-average cluster and could reach $170 in early 2026 and new highs by mid-year. If the follow-through fails, the stock may trade flat around late-October levels until a stronger catalyst appears.
| 
